Volume 28, Number 10—October 2022
Research
SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain
Table 3
Variable | Delta-dominant period |
Omicron-dominant period |
RR§ (95% CI) | p value | |||
---|---|---|---|---|---|---|---|
Patients† | p value‡ | Patients† | p value‡ | ||||
Vaccination status, contacts | |||||||
Vaccinated | 50/101 (49.5) | 0.1 | 112/124 (90.3) | 0.3 | 6.48 (3.0–13.8) | <0.001 | |
Unvaccinated | 35/56 (62.5) | 28/29 (96.6) | 10.4 (1.2–82.5) | 0.03 | |||
Vaccinated, <20 wk | 23/62 (37.1) | 0.002 |
59/65 (90.8) | 0.8 |
9.16 (3.4–25.0) | <0.001 | |
Vaccinated, >20 wk |
27/39 (69.3) |
52/58 (89.7) |
2.91 (0.8–10.2) |
0.1 |
|||
Vaccination status, index | |||||||
Vaccinated | 67/112 (59.8) | 0.02 | 108/120 (90.0) | 0.2 | 3.99 (2.0–8.1) | <0.001 | |
Unvaccinated | 18/45 (40.0) | 32/33 (97.0) | 43.5 (5.1–369.9) | 0.001 |
*RR, relative risk †Values are no. infected/total no. (%) patients in each strata. ‡p values for differences between vaccinated and unvaccinated groups. §RR between Omicron vs. Delta variant, adjusted by age of contact.
Page created: August 11, 2022
Page updated: September 20, 2022
Page reviewed: September 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.